Injective Price Soars as DeFi Project Hits Mainstream Attention

Injective is a blockchain project focused on decentralized finance (DeFi). It aims to make trading faster, cheaper, and fully decentralized. The INJ token has gained strong interest during market cycles due to its goal of providing fast transactions and low fees.

The Injective network is built using the Cosmos software development kit and supports interoperability with other blockchains like Ethereum and Solana. The project launched in 2020 by Eric Chen and Albert Chon, who have strong backgrounds in technology and finance.

Injective focuses on advanced financial products, including spot assets, futures, and derivatives, all traded on-chain through smart contracts. This reduces counterparty risk and increases transparency. The INJ token has several core uses: paying transaction fees, supporting staking, and governance through voting on protocol upgrades.